Alzheimer's disease

WASHINGTON (AP) — About a million Americans a year are expected to develop dementia by 2060, roughly double today’s toll, researchers reported Monday. That estimate is based on a new study that found a higher lifetime risk than previously thought:... Read More

WASHINGTON (AP) — New blood tests could help doctors diagnose Alzheimer’s disease faster and more accurately, researchers reported Sunday – but some appear to work far better than others. It’s tricky to tell if memory problems are caused by Alzheimer’s. That requires... Read More

WASHINGTON (AP) — U.S. officials have approved another Alzheimer’s drug that can modestly slow the disease, providing a new option for patients in the early stages of the incurable, memory-destroying ailment. The Food and Drug Administration approved Eli Lilly’s Kisunla on Tuesday for... Read More

WASHINGTON (AP) — For the first time, researchers have identified a genetic form of late-in-life Alzheimer’s disease — in people who inherit two copies of a worrisome gene. Scientists have long known a gene called APOE4 is one of many... Read More

WASHINGTON — Engaging the primary care workforce in the diagnosis process of Alzheimer’s disease would accelerate the delivery of disease-modifying therapies, while easing the pressures already being experienced by overwhelmed neurology and geriatric practices, a new Rand report says. The... Read More

WASHINGTON — The Food and Drug Administration on Thursday gave its first approval to a drug that can slow the progression of Alzheimer's disease. In a press release the agency said its full approval of lecanemab, known by the brand... Read More

An experimental drug that removes a substance called amyloid — a toxic protein — from the brain appears to slow down Alzheimer's disease. The drug, lecanemab, reduced the rate of cognitive decline by 27% in a study of nearly 1,800... Read More

WASHINGTON — Despite the results of a previous study, sildenafil (Viagra) and tadalafil (Cialis) may not be suitable candidates for treating dementia, according to the National Institutes of Health. The institute recently delved into the situation with its Drug Repurposing... Read More

WASHINGTON — Despite pressure to go another way, Medicare on Thursday evening announced it will only cover the new Alzheimer’s disease drug Aduhelm for people participating in a clinical trial. The decision came as something of a surprise as Medicare... Read More